Carregant...
An Update on Pharmacotherapy for Leishmaniasis
INTRODUCTION: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL). The treatment of leishmaniasis is challenging and the armamentarium of drugs is small, duration of treatment is long, and most drugs are toxic. AREAS COVE...
Guardat en:
| Publicat a: | Expert Opin Pharmacother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293334/ https://ncbi.nlm.nih.gov/pubmed/25346016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2015.973850 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|